The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.
Related Articles

News
UC San Diego Announces 2022 Undergraduate Library Research Prize Winners
September 1, 2022
sandiegobiotech
News, UCSD News
Comments Off on UC San Diego Announces 2022 Undergraduate Library Research Prize Winners
Five UC San Diego students have been selected to receive the annual Undergraduate Library Research Prize (ULRP), an annual awards program that enriches the undergraduate student experience at UC San Diego by pro… […]

News
Making Space Travel Inclusive for All
October 28, 2021
sandiegobiotech
News, UCSD News
Comments Off on Making Space Travel Inclusive for All
???????In a weightless, microgravity environment like space, what do ability and disability look like? How can someone with partial sight or impaired mobility navigate in a confined space like the space station?… […]